Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high enantioselectivity. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN110452150A reveals high-purity axial chiral indole-naphthalene synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Patent CN119320392A details a green catalytic route for Rucaparib. This report analyzes cost reduction in API manufacturing and supply chain reliability for procurement teams.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.
Novel synthesis method offers high enantioselectivity and significant cost reduction for chiral catalyst manufacturing supply chains globally ensuring reliable pharmaceutical intermediates
Patent CN106366054B details non-metal catalytic coupling for ketone synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113620795B details a novel Rh-catalyzed route to benzocycloheptenones. Discover cost-effective API intermediate manufacturing with high scalability.
Patent CN113735867B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis for high-purity antitumor intermediates, offering significant cost reduction and supply reliability.
Novel chiral phosphoric acid catalysis enables high-purity pharmaceutical intermediates with scalable production capabilities and significant cost reduction for global supply chains demanding reliable API intermediate sources.
Novel chiral indole synthesis method offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring cost reduction and supply reliability.
Patent CN105566429B details a novel one-step reduction for high-purity amorphous Obeticholic Acid Form 1, offering significant cost and supply chain advantages.
Patent CN118878543A reveals a novel synthesis for axial chiral compounds with high ee. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN118084763B reveals mild synthesis for high-purity intermediates. Enables cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel resolution method for axially chiral indole oxides offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN115385916B details chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN113735867B reveals high-yield chiral synthesis for anticancer leads. Offers cost reduction in API intermediate manufacturing and supply chain reliability.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.